TP53 and breast carcinoma: Observed differences and similarities between our IHC study in breast cancer [12] and the findings described herein may be related to differences in TP53 mutation status or other genetic variants within TP53 that regulate p53 isoform expression such as mutation in the internal ribosome entry sites, introns, or in splice sites [45–48].